Yang De Marinis

Yang De Marinis

Associate Professor, Chair Professor, Docent, Associate researcher, PhD

Personal profile


Yang De Marinis, PhD, is Associate Professor at the Department of Clinical Sciences, Lund University, Sweden. She is also Chair Professor at Shandong University (China), Visiting Scientist at the University of Oxford (UK), and Board Member at Diabetes Sverige (Diabetes Sweden).

Yang De Marinis' research team is focusing on epigenetics and genetics of diabetes complications, biomarker diagnostics, as well as regulation mechanisms of metabolic disorders and multi-centre clinical cohort studies. The group is leading in several cutting edge technologies including genome-wide chromatin immunoprecipitation sequencing, genome engineering by CRISPR/Cas9, machine learning in artificial intelligence (AI) application on clinical cohort studies, and various cell biology and molecular genetic methods.

In 2020, Yang De Marinis founded MedTech company Lundoch Diagnostics, which was listed as one of the 33 best young tech companies in Sweden in 2022. Yang De Marinis is the Chairman of the Board and CEO of Lundoch. www.lundoch.com


Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Free keywords

  • Diabetes
  • Epigenetics
  • Genome engineering
  • AI-Machine Learning
  • clinical cohort study
  • Lundoch Diagnostics


Dive into the research topics where Yang De Marinis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or